In this study, the expression of mlh1, msh2, and msh6 genes and the relative presence of B. fragilis in biopsy specimens of patients with CRC and healthy individuals were investigated by Real-Time PCR to determine whether the presence of this bacterium affects the expression of selected genes that are involved in CRC development. This evidence concerns the gene MLH1 and colorectal carcinoma.